活性维生素D_3及其类似物对肾脏保护作用研究进展
被引量：1
摘要
活性维生素D3及其类似物在调节钙磷代谢、预防佝偻病等方面有着重要的作用,近年来有研究发现其除了调节钙磷代谢作用外,还具有抑制肾素血管紧张素系统、抑制炎症因子分泌、减少细胞外基质沉积和免疫细胞的增殖活化等肾脏保护作用;现就这方面的研究进展作一综述。
出处
《现代实用医学》
2011年第2期238-240,共3页
Modern Practical Medicine
参考文献20
-
1Zitterrnann A, Vitamin D in preventive medicine: are we ignoring the evidence [J]? Br J Nutr, 2007,89(5):552-572.
-
2Andress DL. Vitamin D in chronic kidney disease: a systemic role for selective vit- amin D receptor activation [J]. Kidney'Int, 2006,69(1):33-43.
-
3Zehnder D, Bland R, Chana RS, et al. Synthesis of 1, 25-dihydroxyvitamin D3 by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion [J]. J Am Soc Nepbrol,2002,13(3):621-629.
-
4Wu-Wong JR, Tian J, Nakane M, et al. Cardiovascular disease in chronic kidney failure: the role of VDR activators [J]. Current Opinion in Investigational Drugs, 2006,7(3 ):206-213.
-
5Chen S, Olsen K, Grigsby C, et al. Vit- amin D activates type A natriuretic pep- tide receptor gene transcription in inner medullary collecting duct cells [J]. Kidney Int, 2007,72(3):300-306.
-
6Zhou C, Lu F, Cao K, et al. Calcium-inde pendent and 1, 25 (OH) 2D3-dependent regulation of the renin-angiotensin system in la-hydroxylase knockout mice[J].Kid- ney Int,2008,74(2): 170-179.
-
7Agarwal R, Acharya M, Tian J, et al. Anti proteinuric effect of oral paricalcitol in chronic kidney disease [J].Kidney Int, 2005,68(6):2823-2828.
-
8Kovesdy CP, Ahmadzadeh S, Anderson LIE, et al. Association of activated vitamin D treatment and mortality in chronic kid- ney disease [J].Arch Intern Med,2008,168 (4):397-403.
-
9Li YC. Vitamin D and diabetic nephro pathy [J]. Current Medicine Group,2008,8 (6):464-469.
-
10Li YC. Vitamin D regulation of the renin- angiotensin system [J]. J Cell Biochem, 2003,88(2): 327-331.
同被引文献38
-
1Tian J,Liu Y,Williams LA,et al.Potential role of active vitamin D in retarding the progression of chronic kidney disease[J].Nephrol Dial Transplant,2007,22(2):321-328.
-
2Mehrotra R,Kermah D,Budoff M,et al.Hypovitaminosis D in chronic kidney disease[J].Clin J Am Soc Nephrol,2008,3(4):1144-1151.
-
3Bhan I,Burnett-Bowie SA,Ye J,et al.Clinical measures identify vitamin D deficiency in dialysis[J].Clin J Am Soc Nephrol,2010,5(3):460-467.
-
4Levin A,Bakris GL,Molitch M,et al.Prevalence of abnormal serum vitamin D,PTH,calcium,and phosphorus in patients with chronic kidney disease:results of the study to evaluate early kidney disease[J].Kidney Int,2007,71(1):31-38.
-
5Prytula A,Wells D,Mc Lean T,et al.Urinary and dialysate losses of vitamin D-binding protein in children on chronic peritoneal dialysis[J].Pediatr Nephrol,2012,27(4):643-649.
-
6Bindal ME,Taskapan H.Hypovitaminosis D and insulin resistance in peritoneal dialysis patients[J].Int Urol Nephrol,2011,43(2):527-534.
-
7Barreto DV,Barreto FC,Liabeuf S,et al.Vitamin D affects survival independently of vascular calcification in chronic kidney disease[J].Clin J Am Soc Nephrol,2009,4(6):1128-1135.
-
8Zisman AL,Hristova M,Ho LT,et al.Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease[J].Am J Nephrol,2007,27(1):36-43.
-
9Tomaschitz A,Pilz S,Ritz E,et al.Independent association between 1,25-dihydroxyvitamin D,25-hydroxyvitamin D and the renin-angiotensin system:The Ludwigshafen Risk and Cardiovascular Health(LURIC)Study[J].Clin Chim Acta,2010,411(17/18):1354-1360.
-
10Qiao G,Kong J,Uskokovic M,et al.Analogs of 1alpha,25-dihydroxyvitamin D(3)as novel inhibitors of renin biosynthesis[J].J Steroid Biochem Mol Biol,2005,96(1):59-66.
二级引证文献7
-
1刘娜,薛兰芬,许静,焦亚丽,刘敏.骨化三醇联合贝那普利治疗膜性肾病的疗效观察[J].现代药物与临床,2016,31(1):29-32. 被引量：1
-
2王花,俞敏,吴丽华,王革.原发性肾小球疾病患者血清25(OH)D的变化[J].宁夏医学杂志,2017,39(2):155-156. 被引量：2
-
3杨桦,王艳,肖东星,阿胜,王革.原发性肾小球疾病患者血清25-羟维生素D水平与临床指标的关系[J].宁夏医科大学学报,2017,39(5):585-587. 被引量：1
-
4李虹达,任野平.持续性腹膜透析患者体内维生素D的含量对铁代谢的影响[J].中国血液净化,2017,16(8):516-518.
-
5王肖志,王珍,张文川.血清25-羟维生素D在原发性肾小球疾病患者中的变化情况[J].湖北科技学院学报（医学版）,2019,33(2):152-154. 被引量：2
-
6哈利,王琴,杨烨.1,25(OH)_(2)D_(3)对2型糖尿病大鼠肾功能损伤的保护作用及SIRT4表达水平影响研究[J].职业与健康,2022,38(16):2203-2207. 被引量：2
-
7高连彬,王丽,王建宾,李媛,韩瑜.探讨帕立骨化醇抑制血管紧张素活性减轻足细胞损伤的有效性[J].中国妇幼健康研究,2016,27(S2):221-222.
-
1叶金朝.活性维生素D3的临床应用[J].医药月刊,1991(5):9-11.
-
2汪永辉,宋卫强,刘苗,文鹏,陆群.活性维生素D_3类药物构效关系的研究进展[J].华西药学杂志,2014,29(4):455-459. 被引量：6
-
3韩少霞.活性维生素D_3胶囊[J].中国新药杂志,1994,3(5):34-34.
-
4文鹏,赵梨,吴坚,陆群.活性维生素D_3类药物的研究进展[J].华西药学杂志,2011,26(1):87-90. 被引量：5
-
5娄朝晅,王学廷.活性维生素D_3加钙剂对绝经后骨质疏松症患者骨代谢生化指标的影响[J].洛阳医专学报,2001,19(4):275-276. 被引量：1
-
6胡二营,单晓燕.帕立骨化醇合成路线图解[J].中国医药工业杂志,2016,47(5):648-650.
-
7俞银芳,刘兆鹏.活性维生素D_3类药物研究概况[J].中国药物化学杂志,2006,16(5):311-315. 被引量：13
-
8刘艳姝,刘文思,刘中柱,史为伍,牛效清.活性维生素D_3抑制UUO模型大鼠肾间质纤维化作用的研究及其对TGF-β1,α-SMA表达的影响[J].黑龙江医药科学,2013,36(2):72-73. 被引量：7
-
9吴俊,梅长林.活性维生素D在肾脏病领域的应用进展[J].实用药物与临床,2005,8(5):40-43. 被引量：8
-
10吴欣,蒋文勇,刘畅,于黔.活性维生素D_3对高糖诱导的人肾小管上皮细胞中α-SMA和FN表达的影响[J].华西药学杂志,2013,28(2):147-149.
